Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L (2023)
Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Nat Commun, 14 (1), 12
DOI 10.1038/s41467-022-35700-9, PubMed 36596811

Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L (2023)
Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
Nat Commun, 14 (1), 3874
DOI 10.1038/s41467-023-39601-3, PubMed 37391415

Arranz L (2022)
The Hematology of Tomorrow Is Here-Preclinical Models Are Not: Cell Therapy for Hematological Malignancies
Cancers (Basel), 14 (3)
DOI 10.3390/cancers14030580, PubMed 35158848